[Serious adverse effects of methotrexate therapy in patients with rheumatic arthritis].
Purokivi
M
M
KYS:n keuhkosairauksien klinikka PL 1777, 70211 Kuopio. minna.purokivi@kuh.fi
Myllykangas-Luosujärvi
R
R
Jantunen
E
E
D000368:Aged; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001853:Bone Marrow / Q000187:drug effects / Q000473:pathology; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D008168:Lung / Q000187:drug effects; D008297:Male; D008727:Methotrexate / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D009503:Neutropenia / Q000139:chemically induced / Q000150:complications; D010198:Pancytopenia / Q000139:chemically induced / Q000150:complications; D011014:Pneumonia / Q000139:chemically induced
D018501:Antirheumatic Agents; D008727:Methotrexate